ovarian: Ovarian Cancer Survival Data
Description
Survival in a randomised trial comparing two treatments for
ovarian cancerformat
ll{
futime: survival or censoring time
fustat: censoring status
age: in years
resid.ds: residual disease present (1=no,2=yes)
rx: treatment group
ecog.ps: ECOG performance status (1 is better, see reference)
}source
Terry TherneauReferences
Edmunson, J.H., Fleming, T.R., Decker, D.G.,
Malkasian, G.D., Jefferies, J.A., Webb, M.J., and Kvols, L.K.,
Different Chemotherapeutic Sensitivities and Host Factors Affecting
Prognosis in Advanced Ovarian Carcinoma vs. Minimal Residual Disease.
Cancer Treatment Reports, 63:241-47, 1979.